Diagnostic values of SurePath liquid‐based cytology versus conventional smear in thyroid aspiration samples: A 13‐year experience at a single institution

Wen‐Ying Lee,Hsiu‐Chu Wang,Lee‐E Huang,Min‐Hui Tseng,Shu‐Hui Chiang,Ching‐Chien Lee
DOI: https://doi.org/10.1002/dc.25319
2024-04-10
Diagnostic Cytopathology
Abstract:Background Fine needle aspiration cytology (FNAC) is the most useful tool in the diagnosis of thyroid nodules. Liquid‐based cytology (LBC) is replacing the conventional smear (CS) for evaluation of thyroid FNAC. In our institution, thyroid FNAC preparation was changed from CS to LBC SurePath in July 2016. This study aimed to compare the diagnostic value of SurePath with that of CS in thyroid lesions. Methods A total of 35,406 samples of thyroid FNAC (11,438 CS and 23,968 SurePath), collected from January 2010 to December 2022, were included in this study. We also examined the malignant rate using the surgical pathology diagnosis as the gold standard. Results The distribution of TBSRTC cytological categories was equivalent between CS and SurePath. The rate of nondiagnostic/unsatisfactory category was higher in CS compared to SurePath (43.4% vs. 22.3%; p
pathology,medical laboratory technology
What problem does this paper attempt to address?